Total Payments
$63,396
2024 Payments
$1,165
Companies
58
Transactions
687
Medicare Patients
10,556
Medicare Billing
$1.2M
Payment Breakdown by Category
Research$38,724 (61.1%)
Food & Beverage$15,509 (24.5%)
Consulting$6,300 (9.9%)
Travel$2,555 (4.0%)
Education$307.26 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $38,724 | 9 | 61.1% |
| Food and Beverage | $15,509 | 666 | 24.5% |
| Consulting Fee | $6,300 | 2 | 9.9% |
| Travel and Lodging | $2,555 | 6 | 4.0% |
| Education | $307.26 | 4 | 0.5% |
Payments by Type
Research
$38,724
9 transactions
General
$24,672
678 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $24,674 | 1 | $0 (2021) |
| Philips Electronics North America Corporation | $15,558 | 69 | $0 (2021) |
| Boston Scientific Corporation | $8,796 | 93 | $0 (2024) |
| Surmodics, Inc. | $3,219 | 8 | $0 (2018) |
| ABIOMED | $1,073 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,070 | 79 | $0 (2024) |
| Abbott Laboratories | $917.58 | 43 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $853.18 | 49 | $0 (2024) |
| PFIZER INC. | $764.91 | 49 | $0 (2024) |
| The Spectranetics Corporation | $692.06 | 24 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,165 | 60 | Boston Scientific Corporation ($247.13) |
| 2023 | $1,945 | 78 | Boston Scientific Corporation ($419.82) |
| 2022 | $2,214 | 83 | Boston Scientific Corporation ($537.77) |
| 2021 | $25,905 | 60 | Eli Lilly and Company ($24,674) |
| 2020 | $4,900 | 41 | Philips Electronics North America Corporation ($4,050) |
| 2019 | $15,701 | 108 | Philips Electronics North America Corporation ($10,702) |
| 2018 | $5,894 | 136 | Surmodics, Inc. ($3,219) |
| 2017 | $5,672 | 121 | BOSTON SCIENTIFIC CORPORATION ($2,921) |
All Payment Transactions
687 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ARGON MEDICAL DEVICES, INC. | Clot Management (Device) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: VASCULAR | ||||||
| 12/10/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: VTE | ||||||
| 12/10/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: VTE | ||||||
| 12/03/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Boston Scientific Corporation | EkoSonic (Device) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: EkoSonic_PI | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $24.23 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: VTE | ||||||
| 10/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $31.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $13.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.04 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $5.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $34.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: VTE | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACEBO IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY (SUMMIT | Eli Lilly and Company | $24,674 | 1 |
| ILLUMENATE | Philips Electronics North America Corporation | $14,050 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,424 | 3,113 | $914,055 | $257,819 |
| 2022 | 27 | 2,519 | 3,295 | $1.0M | $281,012 |
| 2021 | 34 | 2,925 | 3,780 | $1.1M | $318,942 |
| 2020 | 33 | 2,688 | 3,508 | $1.6M | $296,789 |
Total Patients
10,556
Total Services
13,696
Medicare Billing
$1.2M
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 191 | 191 | $197,685 | $58,471 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 395 | 568 | $116,440 | $47,831 | 41.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 153 | 165 | $71,940 | $21,276 | 29.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 103 | 125 | $65,375 | $20,329 | 31.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 114 | 121 | $49,973 | $14,902 | 29.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 189 | 196 | $97,266 | $14,534 | 14.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 95 | 102 | $27,438 | $10,325 | 37.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 19 | 24 | $32,315 | $9,882 | 30.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 45 | 45 | $31,410 | $8,808 | 28.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 156 | 159 | $26,777 | $8,268 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 128 | $18,048 | $7,867 | 43.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 458 | 722 | $40,432 | $6,618 | 16.4% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 100 | 123 | $21,525 | $5,761 | 26.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 25 | 97 | $12,998 | $4,111 | 31.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $11,426 | $3,889 | 34.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 26 | $5,278 | $2,404 | 45.6% |
| 75630 | Review by radiologist of abdominal aorta and both leg arteries image | Facility | 2023 | 25 | 31 | $6,944 | $2,201 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,260 | $2,087 | 33.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 40 | 40 | $9,320 | $1,842 | 19.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 21 | 21 | $5,544 | $1,677 | 30.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 14 | 17 | $2,397 | $1,059 | 44.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 11 | 12 | $4,152 | $999.24 | 24.1% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Facility | 2023 | 15 | 15 | $45,750 | $975.45 | 2.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 78 | 78 | $3,900 | $832.72 | 21.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 23 | 35 | $2,485 | $577.25 | 23.2% |
About Dr. William Eaves, MD
Dr. William Eaves, MD is a Cardiovascular Disease healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801861240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Eaves, MD has received a total of $63,396 in payments from pharmaceutical and medical device companies, with $1,165 received in 2024. These payments were reported across 687 transactions from 58 companies. The most common payment nature is "" ($38,724).
As a Medicare-enrolled provider, Eaves has provided services to 10,556 Medicare beneficiaries, totaling 13,696 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Shreveport, LA
- Active Since 02/21/2006
- Last Updated 06/24/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1801861240
Products in Payments
- Stellarex (Device) $14,065
- ANGIOJET (Device) $3,516
- SurVeil (Device) $3,219
- ANGIOJET ZELANTEDVT THROMBECTOMY CATHETER (Device) $2,800
- Impella (Device) $1,073
- ENTRESTO (Drug) $856.43
- LifeVest (Device) $853.18
- ELIQUIS (Drug) $663.36
- IGT D Peripheral (Device) $553.84
- IGT_D Peripheral (Device) $443.27
- WatchPAT (Device) $402.94
- FLOWTRIEVER CATHETER, S (Device) $394.43
- AVVIGO Guidance System (Device) $378.09
- STELLAREX (Device) $332.38
- MULTAQ (Drug) $331.98
- Supera peripheral stent system (Device) $301.78
- ELUVIA (Device) $289.40
- CVX-300 (Device) $228.67
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $224.00
- Endurant (Device) $221.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Shreveport
Dr. James Smith, M.d, M.D
Cardiovascular Disease — Payments: $59,052
Cardiovascular Disease $59,052
Dr. Paul Davis, M.d, M.D
Cardiovascular Disease — Payments: $56,634
Cardiovascular Disease $56,634
Tarek Helmy, Md, MD
Cardiovascular Disease — Payments: $51,880
Cardiovascular Disease $51,880
Anil Chhabra, Md, MD
Cardiovascular Disease — Payments: $48,787
Cardiovascular Disease $48,787
Eric Reeves, M.d, M.D
Cardiovascular Disease — Payments: $37,592
Cardiovascular Disease $37,592
Basel Kasabali, Md, MD
Cardiovascular Disease — Payments: $34,523
Cardiovascular Disease $34,523